150 related articles for article (PubMed ID: 16681809)
1. Epidemiological and aetiological study on tinea pedis and onychomycosis in Algeria.
Djeridane A; Djeridane Y; Ammar-Khodja A
Mycoses; 2006 May; 49(3):190-6. PubMed ID: 16681809
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for the development of tinea pedis and onychomycosis: Real-world evidence from a single-podiatry center, large-scale database in Japan.
Ogawa T; Matsuda A; Ogawa Y; Tanaka R
J Dermatol; 2024 Jan; 51(1):30-39. PubMed ID: 37904622
[TBL] [Abstract][Full Text] [Related]
3. Dermatophytes and other associated fungi in patients attending to some hospitals in Egypt.
Abd Elmegeed AS; Ouf SA; Moussa TA; Eltahlawi SM
Braz J Microbiol; 2015; 46(3):799-805. PubMed ID: 26413063
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of classic Kaposi sarcoma with Trichophyton rubrum-infected onychomycosis and tinea pedis utilizing combination of oral itraconazole and thalidomide.
Chen J; Zheng Y; Zhu C; Lin L; Su H
J Dermatol; 2024 May; 51(5):727-730. PubMed ID: 38087640
[TBL] [Abstract][Full Text] [Related]
5. Efinaconazole Topical Solution, 10%: Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
Markinson BC; Caldwell BD
J Am Podiatr Med Assoc; 2015 Apr; ():. PubMed ID: 25867759
[TBL] [Abstract][Full Text] [Related]
6. Patients with tinea pedis and onychomycosis are more likely to use disinfectants when washing textiles than controls.
Wriedt TR; Skaastrup KN; Andersen PL; Simmelsgaard L; Jemec GBE; Saunte DML
APMIS; 2023 Nov; 131(11):561-563. PubMed ID: 36645313
[No Abstract] [Full Text] [Related]
7. Dermatophyte antigen kit: A useful diagnostic tool for onychomycosis.
Noguchi H; Matsumoto T; Mimura Y; Kubo M; Higuchi S; Kashiwada-Nakamura K; Kimura U; Hiruma M; Fukushima S
J Dermatol; 2023 Dec; 50(12):1614-1618. PubMed ID: 37605440
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of tinea pedis and onychomycosis treatment in people with diabetes: a systematic review.
Matricciani L; Talbot K; Jones S
J Foot Ankle Res; 2011 Dec; 4():26. PubMed ID: 22136082
[TBL] [Abstract][Full Text] [Related]
9. Internal environment of footwear is a risk factor for tinea pedis.
Sasagawa Y
J Dermatol; 2019 Nov; 46(11):940-946. PubMed ID: 31436337
[TBL] [Abstract][Full Text] [Related]
10. pH- and Matrix Metalloproteinase-Responsive Multifunctional Bilayer Microneedles Platform for Treatment of Tinea Pedis.
Yang M; Pan L; Tian H; Zhou T; Xin H; Feng Y; Zou X; Lv Z; Xu Y; Jin X; Gui S; Lu X
ACS Biomater Sci Eng; 2024 May; 10(5):3108-3119. PubMed ID: 38659287
[TBL] [Abstract][Full Text] [Related]
11. The prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients.
Kuvandik G; Cetin M; Genctoy G; Horoz M; Duru M; Akcali C; Satar S; Kiykim AA; Kaya H
BMC Infect Dis; 2007 Aug; 7():102. PubMed ID: 17760994
[TBL] [Abstract][Full Text] [Related]
12. Tinea pedis and onychomycosis frequency in diabetes mellitus patients and diabetic foot ulcers. A cross sectional - observational study.
Akkus G; Evran M; Gungor D; Karakas M; Sert M; Tetiker T
Pak J Med Sci; 2016; 32(4):891-5. PubMed ID: 27648034
[TBL] [Abstract][Full Text] [Related]
13. Clinical Diagnosis and Laboratory Testing of Abnormal Appearing Toenails: A Retrospective Assessment of Confirmatory Testing for Onychomycosis in the United States, 2022-2023.
Gupta AK; Wang T; Cooper EA; Lincoln SA; Foreman HC; Scherer WP; Bakotic WL
J Fungi (Basel); 2024 Feb; 10(2):. PubMed ID: 38392821
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Factors Associated With Tinea Pedis Among Diabetic Patients in Saudi Arabia: A Descriptive Cross-Sectional Study.
Alhammadi N; Al-Jallal M; AlKaabi HA; Malibari WM; Al Jallal RS; Almarshad AS; Binshalhoub FH; Albalawi AN; Adam TA; Al-Khairat AH
Cureus; 2023 Dec; 15(12):e51210. PubMed ID: 38288233
[TBL] [Abstract][Full Text] [Related]
15. Global prevalence of onychomycosis in general and special populations: An updated perspective.
Gupta AK; Wang T; Polla Ravi S; Mann A; Bamimore MA
Mycoses; 2024 Apr; 67(4):e13725. PubMed ID: 38606891
[TBL] [Abstract][Full Text] [Related]
16. Mendelian Randomization Analysis Supports Causal Effect of Type II Diabetes Mellitus on Onychomycosis.
Choo ZN; Lipner SR
Skin Appendage Disord; 2024 Jun; 10(3):220-223. PubMed ID: 38835708
[TBL] [Abstract][Full Text] [Related]
17. Tinea Pedis, Peripheral Vascular Disease, and Male Gender are Associated with Higher Odds of Onychomycosis in a Retrospective Case-Control Study of 1257 Onychodystrophy Patients.
Axler E; Katsiaunis A; Charla JN; W Gold JA; Lipner SR
J Am Acad Dermatol; 2024 May; ():. PubMed ID: 38754629
[No Abstract] [Full Text] [Related]
18. Prevalence and risk factors for onychomycosis in acute care dermatology wards.
Inoue T; Watabe D; Furukawa M; Goto M; Kamada H; Sato Y; Arakawa N; Miura S; Sato T; Yasuhira S; Tsunemi Y; Amano H
J Dermatol; 2024 Apr; ():. PubMed ID: 38558466
[TBL] [Abstract][Full Text] [Related]
19. Concerning rates of laboratory-confirmed antifungal-resistant onychomycosis and tinea pedis: An online survey of podiatrists, United States.
Benedict K; Gold JAW; Jones CT; Tushla LA; Lipner SR; Joseph WS; Tower DE; Elewski B; Pappas PG
Health Sci Rep; 2023 Nov; 6(11):e1694. PubMed ID: 38028688
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
